Germline mutations in SPI1 and MADD do not contribute to familial chronic lymphocytic leukaemia
暂无分享，去创建一个
[1] R. Houlston,et al. Familial chronic lymphocytic leukemia. , 2006, Seminars in oncology.
[2] Achim Leutz,et al. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1 , 2006, Nature Genetics.
[3] M. Dyer,et al. A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci. , 2005, American journal of human genetics.
[4] Pu Zhang,et al. Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element , 2005, Molecular and Cellular Biology.
[5] V. Chow,et al. Antisense abrogation of DENN expression induces apoptosis of leukemia cells in vitro, causes tumor regression in vivo and alters the transcription of genes involved in apoptosis and the cell cycle , 2004, International journal of cancer.
[6] M. Minden,et al. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. , 2002, Blood.
[7] B. Prabhakar,et al. Contrasting Effects of IG20 and Its Splice Isoforms, MADD and DENN-SV, on Tumor Necrosis Factor α-induced Apoptosis and Activation of Caspase-8 and -3* , 2001, The Journal of Biological Chemistry.
[8] E. Montserrat,et al. Chronic lymphocytic leukaemia/small lymphocytic leukaemia. , 2001 .
[9] A. Schievella,et al. MADD, a Novel Death Domain Protein That Interacts with the Type 1 Tumor Necrosis Factor Receptor and Activates Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.